Patients who complete a microdose protocol typically achieve 510% baseline body weight reduction, comparable to standard protocols, because the total drug exposure over months remains substantial
Most patients experience an improvement in nausea symptoms within a few weeks
Based on data derived from our previous study [8], inclusion of 16 participants was calculated to provide at least 90% power (at = 0.01 to allow for subgroup comparisons) to detect a 20% difference in glucose iAUC 0120min between metformin treatments and the control
Chromium supplements have become increasingly popular lately due to claims about their potential role in weight loss, reducing body fat, and promoting metabolic health
March 5, a federal judge rejected the request for a preliminary injunction
In Study 6, the proportions of patients who discontinued study drug were 7.9%, 6.5%, and 3.0% for WEGOVY 1.7 mg, WEGOVY 2.4 mg, and placebo, respectively